Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1998 1
2013 1
2020 2
2021 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Intraoperative Neuromonitoring Does Not Reduce the Risk of Temporary and Definitive Recurrent Laryngeal Nerve Damage during Thyroid Surgery: A Systematic Review and Meta-Analysis of Endoscopic Findings from 73,325 Nerves at Risk.
Cozzi AT, Ottavi A, Lozza P, Maccari A, Borloni R, Nitro L, Felisati EG, Alliata A, Martino B, Cacioppo G, Fuccillo M, Rosso C, Pipolo C, Felisati G, De Pasquale L, Saibene AM. Cozzi AT, et al. Among authors: ottavi a. J Pers Med. 2023 Sep 23;13(10):1429. doi: 10.3390/jpm13101429. J Pers Med. 2023. PMID: 37888040 Free PMC article. Review.
Understanding and combating age-related muscle weakness: MYOAGE challenge.
Butler-Browne G, McPhee J, Mouly V, Ottavi A. Butler-Browne G, et al. Among authors: ottavi a. Biogerontology. 2013 Jun;14(3):229-30. doi: 10.1007/s10522-013-9438-3. Epub 2013 Jun 23. Biogerontology. 2013. PMID: 23793985 Free PMC article. No abstract available.
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone.
Choi EM, Lacarra B, Afolabi MO, Ale BM, Baiden F, Bétard C, Foster J, Hamzé B, Schwimmer C, Manno D, D'Ortenzio E, Ishola D, Keita CM, Keshinro B, Njie Y, van Dijck W, Gaddah A, Anumendem D, Lowe B, Vatrinet R, Lawal BJ, Otieno GT, Samai M, Deen GF, Swaray IB, Kamara AB, Kamara MM, Diagne MA, Kowuor D, McLean C, Leigh B, Beavogui AH, Leyssen M, Luhn K, Robinson C, Douoguih M, Greenwood B, Thiébaut R, Watson-Jones D; EBOVAC-3/EBL2005 Study Team. Choi EM, et al. Lancet Glob Health. 2023 Nov;11(11):e1743-e1752. doi: 10.1016/S2214-109X(23)00410-2. Lancet Glob Health. 2023. PMID: 37858585 Free article. Clinical Trial.
Erythema Multiforme Major following SARS-CoV-2 vaccine.
Saibene AM, Alliata A, Cozzi AT, Ottavi A, Spagnolini S, Pipolo C, Maccari A, Felisati G. Saibene AM, et al. Among authors: ottavi a. Clin Case Rep. 2021 Oct 13;9(10):e04947. doi: 10.1002/ccr3.4947. eCollection 2021 Oct. Clin Case Rep. 2021. PMID: 34667612 Free PMC article.
Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial.
Pollard AJ, Launay O, Lelievre JD, Lacabaratz C, Grande S, Goldstein N, Robinson C, Gaddah A, Bockstal V, Wiedemann A, Leyssen M, Luhn K, Richert L, Bétard C, Gibani MM, Clutterbuck EA, Snape MD, Levy Y, Douoguih M, Thiebaut R; EBOVAC2 EBL2001 study group. Pollard AJ, et al. Lancet Infect Dis. 2021 Apr;21(4):493-506. doi: 10.1016/S1473-3099(20)30476-X. Epub 2020 Nov 17. Lancet Infect Dis. 2021. PMID: 33217361 Clinical Trial.
Passage time statistics in semiconductor laser turn on.
Mecozzi A, Piazzolla S, D'Ottavi A, Spano P. Mecozzi A, et al. Among authors: d ottavi a. Phys Rev A Gen Phys. 1988 Sep 15;38(6):3136-3138. doi: 10.1103/physreva.38.3136. Phys Rev A Gen Phys. 1988. PMID: 9900739 No abstract available.